HTCR
HeartCore Enterprises, Inc.
There isn't enough reported data to score HTCR yet.
HTCR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Weak | |
| Strong |
HTCR's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
HTCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 0.4x | $1.34 | — |
| Cheap | 0.5x | $1.65 | +23% |
| Fair | 0.8x | $2.59 | +94% |
| Expensive | 6.7x | $23.16 | +1629% |
Historical ranges are pointers, not guarantees.
HTCR's PE is 0.4x, but its earnings don't support one, so it isn't a reliable read right now.
HTCR Forward outlook
There aren't enough analyst estimates for HTCR to show an outlook.
HTCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.46 | +$3.86 |
| Q1 2026 | $5.71 | +$8.71 |
| Q4 2025 | $4.40 | +$5.80 |
| Q3 2025 | -$10.60 | -341% |
| Q2 2025 | -$0.40 | +$8.00 |
| Q1 2025 | -$3.00 | +$4.40 |
| Q4 2024 | -$1.40 | +$2.80 |
| Q3 2024 | $4.40 | +$7.00 |
HTCR has returned to profit: it earned $3.46 per share over the past year, after losing money the year before.
HTCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $321.4K | -93% |
| Q1 2026 | $1.2M | -65% |
| Q4 2025 | $1.9M | -44% |
| Q3 2025 | $3M | -83% |
| Q2 2025 | $4.7M | +17% |
| Q1 2025 | $3.6M | -29% |
| Q4 2024 | $3.4M | +3.5% |
| Q3 2024 | $17.9M | +281% |
HTCR's revenue has slid since its 2024 peak: $321,428 last quarter, down 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -256% | -259 points |
| Q1 2026 | -124% | -89 points |
| Q4 2025 | -66% | +220 points |
| Q3 2025 | -0.4% | -68 points |
| Q2 2025 | 2.3% | +39 points |
| Q1 2025 | -35% | -21 points |
| Q4 2024 | -286% | -191 points |
| Q3 2024 | 68% | +106 points |
HTCR's operating margin was −256% last quarter, down 259 points from the same quarter a year ago, near the bottom of its range since 2020.
HTCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$1.2M | +$846.2K |
| Q4 2025 | -$136.1K | +$1.1M |
| Q3 2025 | -$306.1K | +$1.7M |
| Q4 2024 | -$1.3M | +$604.4K |
| Q3 2024 | -$2M | -$613.5K |
| Q4 2023 | -$1.9M | -$1.3M |
| Q3 2023 | -$1.4M | +$697.9K |
| Q2 2023 | -$491.5K | -271% |
HTCR has burned cash in most quarters: −$3M over the past year, against −$7M the year before.
HTCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | 10.1x | High |
| Q4 2024 | -0.6x | Net Cash |
| Q3 2024 | 0.1x | Very low |
| Q4 2021 | 18.6x | High |
| Q3 2021 | 7.6x | High |
HTCR has more cash than debt.
HTCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.5 | Oversold |
| Stochastic | 15.0 | Oversold |
HTCR's weekly RSI is 28 (oversold) and its Stochastic is 15 (oversold).
HTCR PE vs Technology Sector
| Metric | HTCR | Sector median | Relative |
|---|---|---|---|
| PE | 0.4x | 28x | 99% below |
| PE % | 2 | 49 | 47 pts below |
HTCR is trading at 0.4x earnings, a 99% discount to the Technology sector's median of 28x, though its earnings don't support one.
HTCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.65 | 19% below |
| 20 week MA | $2.14 | 37% below |
| 50 week MA | $3.70 | 64% below |
| 100 week MA | $10.6 | 87% below |
| 200 week MA | $14.9 | 91% below |
HTCR is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
HTCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $82.6 | $16.4 | -80% |
| 2023 | $16.4 | $12.8 | -22% |
| 2024 | $12.8 | $31.0 | +143% |
| 2025 | $31.0 | $6.92 | -78% |
| 2026 YTD | $6.92 | $1.34 | -81% |
HTCR's yearly returns have swung widely, from +143% in 2024 to −80% in 2022. It's down 81% so far in 2026.